摘要
目的 探讨超声引导下微波消融(MWA)治疗腹壁子宫内膜异位症(AWE)的安全性和有效性.资料与方法 回顾性收集2014年 8 月—2023年6 月在北京友谊医院接受MWA治疗AWE的患者17例(共 19个病灶).治疗前后使用常规超声、彩色多普勒超声和静脉超声造影观察病灶变化情况.记录治疗后3、6、12个月AWE病灶体积、体积缩小率、疼痛缓解及并发症情况,评估治疗效果.结果 超声造影显示所有病灶均一次完全消融成功.病灶平均初始体积为(7.46±5.82)ml,术后 3、6、12个月随访时体积分别缩小至(4.32±2.76)ml、(2.47±1.68)ml、(1.72±1.16)ml(t=0.423,P=0.005;t=0.198,P=0.001;t=0.556,P=0.002),平均体积缩小率分别为(46.18±24.36)%、(61.43±18.72)%、(74.25±13.26)%.所有患者治疗12个月后腹壁周期性切口疼痛明显减轻或消失.1例患者术后出现局部皮肤灼伤,其余患者未出现严重并发症.结论 MWA治疗AWE安全有效,值得进一步研究.
Abstract
Purpose To investigate the safety and effectiveness of ultrasound-guided microwave ablation(MWA)in the treatment of abdominal wall endometriosis(AWE).Materials and Methods A total of 17 patients(19 lesions)with AWE who underwent MWA in Beijing Friendship Hospital from August 2014 to June 2023 were retrospectively analyzed.Grey-scale and color Doppler flow ultrasonography,and contrast-enhanced ultrasonography were used to observe the lesions before and after treatment.The AWE lesion volume,volume reduction rate,pain relief,and complications were recorded 3,6,and 12 months after treatment to evaluate the treatment efficacy.Results Contrast-enhanced ultrasound showed that all lesions underwent successful treatment with single MWA.The average initial nodule volume was(7.46±5.82)ml,which decreased significantly to(4.32±2.76)ml,(2.47±1.68)ml,(1.72±1.16)ml at 3,6 and 12 months follow-up(t=0.423,P=0.005;t=0.198,P=0.001;t=0.556,P=0.002)with a mean volume reduction rate of(46.18±24.36)%,(61.43±18.72)%,(74.25±13.26)%,respectively.Notably,all 17 patients experienced a significant decrease or complete alleviation of periodic abdominal incision pain at 12-month after treatment.One patient experienced local skin burns after the procedure,while the remaining patients did not experience severe complications.Conclusion MWA is safe and effective for treating AWE,and further research is warranted.
NETL
NSTL
万方数据